HealthDay - FRIDAY, Jan. 18 (HealthDay News) -- A mislabeled over-the-counterproduct described as a dietary supplement appears to have contributed tothe development of aggressive prostate cancer in two men, researchersreport.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.